Successful use of dupilumab for the treatment of atopic dermatitis on the genitals, a neglected anatomical site.
Clin Exp Dermatol
; 47(1): 176-178, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34398987
ABSTRACT
Atopic dermatitis (AD) is a chronic inflammatory disease that may involve any cutaneous site; involvement of the genital area may greatly impair patients' quality of life but, as the inspection of genitals is not usually conducted during the routine physical examination of patients with AD, the genital presentation of AD is frequently neglected and under-reported. We decided to evaluate the incidence of genital AD in patients with moderate-severe AD and the relative response to anti-interleukin (IL)-4/IL-13 dupilumab. In our study, a high incidence of genital AD emerged but the use of dupilumab allowed a generalized improvement.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
/
Dermatologic Agents
/
Interleukin-4 Receptor alpha Subunit
/
Antibodies, Monoclonal, Humanized
/
Genitalia, Female
/
Genitalia, Male
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Dermatol
Year:
2022
Document type:
Article
Affiliation country:
Italia